@Tataki61Very, very sorry to hear about your daughter. I don't...

@Tataki61

Very, very sorry to hear about your daughter.

I don't mean this to come across as advice, but please reconsider "trusting the science and management".

You may view the trial results as "positive" due to some partial and one complete response, but this is not positive in terms of sufficient efficacy to progress the products. So much of the feedback you get from these pages is delusional. The company itself - which always, always, always, hides or minimises bad news - has come out and confirmed that its B-cell platform has been deprioritised. And look at how management did it - buried at the end of a quarterly activities and cashflow report, and then by omission from presentations. The potential of the B-cell platform saw IMU reach a market cap of over $3b, yet even when it became too difficult to hide its ongoing failures (the "no longer recruiting trials"), the company didn't have the decency to announce this explicitly.

Any poster who claims that IMU has only ever made positive announcements is at best delusional and at worst manipulative.

And before you "trust management", just consider that they made capital adequacy declarations on multiple occasions before every capital raise. One one occasion they did this so close to the capital raise announcement that they must have already been negotiating the raise price with the chairman's mates.

Consider the fact that Hopper has sold shares while claiming that everything is hunky-dory with the company. He's removed challengers, ignored shareholder questions and served up arrogance by the bucketload.

Leslie had to embarrassingly withdraw an announced collaboration with a BP company.

Leslie claims she has "no idea" about the SP demise - can't even get herself to say that the discontinuation of the B-cell platform may be a contributor.

The science may have been promising, but didn't get there.

Management has never been trustworthy and they are all ridiculously overpaid. A biotech that stops clinical trials and its management doesn't announce it - what more is there to say?

We all want a cure for cancer, its just not going to come from Imugene.